Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-22-005681
Filing Date
2022-04-21
Accepted
2022-04-21 07:01:16
Documents
4
Period of Report
2022-06-02

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20220602xdef14a.htm DEF 14A 1052433
2 GRAPHIC tmb-20220602xdef14a018.jpg GRAPHIC 132841
3 GRAPHIC tmb-20220602xdef14a001.jpg GRAPHIC 4437
4 GRAPHIC tmb-20220602xdef14a017.jpg GRAPHIC 165211
  Complete submission text file 0001558370-22-005681.txt   1470466
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37581 | Film No.: 22839643
SIC: 2834 Pharmaceutical Preparations